Novel Pharmaceutical Formulation Containing A Biguanide and a Thiazolidinedione Derivative

摘要

A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.